Dystrophic Epidermolysis Bullosa

Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART)

Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa

Evaluation of D-Fi for the Treatment of Wounds Due to DEB

A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa

A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study

Pilot Study of ELK-003 Eye Drops for Treating Ocular Manifestations of Epidermolysis Bullosa

Effect of Ev.FV on Wound Healing in Dystrophic Epidermolysis Bullosa

MSC EVs in Dystrophic Epidermolysis Bullosa

Gynecological Follow-up of Patients With Dystrophic Epidermolysis Bullosa (EBD)

Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa

A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa

A Follow-up Study to Evaluate the Efficacy and Safety of ALLO-ASC-DFU in ALLO-ASC-EB-101 Clinical Trial

Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa

Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene

Ph 3 Efficacy and Safety of B-VEC for the Treatment of DEB

A Phase I/II Study of KB103, a Topical HSV1-COL7, on DEB Patients

Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa

The Natural History of Wounds in Patients With Dystrophic Epidermolysis Bullosa (DEB)

Long-Term Follow-up Protocol

Short Term Observational Study in DEB Patients